My record: ≈400 [Design Issues]

posted by Helmut Homepage – Vienna, Austria, 2024-05-03 16:19 (360 d 03:50 ago) – Posting: # 23980
Views: 4,379

Hi Achievwin,

❝ ❝ BTW, I have seen 4-period full replicate studies with 180 healthy volunteers…

❝ wow for a full replicate N=400 the sponsor has deep pockets…

Nope. ≈400 (parallel), 180 4-period full replicate1 but there are even larger ones (252 subjects started, 238 completers).2 If your drug is a blockbuster1 and you have to change the formulation, you would do it.


  1. U.S. National Library of Medicine [2014-05-19] – Identifier NCT01290757
  2. Davit BM, Patel DT. Bioequivalence of Highly Variable Drugs. In: Yu LX, Li BV, editors. FDA Bioequivalence Standards. New York: aapspress/Springer; 2014. p. 151–2.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,673 registered users;
96 visitors (0 registered, 96 guests [including 2 identified bots]).
Forum time: 20:10 CEST (Europe/Vienna)

There are two possible outcomes: if the result confirms the
hypothesis, then you’ve made a measurement. If the result is
contrary to the hypothesis, then you’ve made a discovery.    Enrico Fermi

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5